Hepcitaj-SV 400 mg/100 mg Tablet

Hepcitaj-SV 400 mg/100 mg Tablet is an oral antiviral medicine that contains sofosbuvir 400 mg and velpatasvir 100 mg in each tablet. It is used to treat chronic hepatitis C infection, which is a viral infection that can damage the liver over time. This combination belongs to the direct-acting antiviral class and is taken as part of a doctor-selected treatment plan for hepatitis C.

How it works: Sofosbuvir blocks a hepatitis C enzyme called NS5B, which the virus needs to copy its genetic material. Velpatasvir blocks another viral protein called NS5A, and together in this tablet they help stop the virus from multiplying in the body.

Hepcitaj-SV 400 mg/100 mg Tablet is a full-dose fixed combination tablet, so each tablet already contains the standard 400 mg/100 mg amounts of sofosbuvir and velpatasvir. It is not a lower starter strength, and it is used only when a clinician has decided this exact dose fits the treatment plan for the patient’s hepatitis C genotype, liver status, and other medicines. Because there are no other strengths or forms of Hepcitaj-SV listed here, this tablet represents the brand’s complete dosing form rather than a step-up from a smaller sibling product.

• Treatment of chronic hepatitis C virus infection
• Part of direct-acting antiviral therapy
• Used in adults and some pediatric patients as directed by a clinician
• May be used with other medicines in selected patients
• Helps reduce viral load and support liver health

• Swallow the Hepcitaj-SV 400 mg/100 mg Tablet whole with water; do not crush, chew, or split it unless your doctor or pharmacist specifically tells you to.
• Take it at the same time each day to help keep treatment on schedule.
• This tablet may be taken with or without food.
• If you also take an antacid, separate it from Hepcitaj-SV 400 mg/100 mg Tablet by several hours as directed, because acid-reducing medicines can affect absorption.
• Keep taking the full prescribed course even if you feel well, because hepatitis C often has no symptoms while it is still active.

Each Hepcitaj-SV 400 mg/100 mg Tablet provides sofosbuvir 400 mg plus velpatasvir 100 mg per tablet, which is the standard fixed-dose amount in this product. It is commonly taken once daily, but the exact schedule, treatment length, and whether additional medicines are needed are decided by the prescriber based on the patient’s condition. Do not take more than the prescribed daily dose of Hepcitaj-SV 400 mg/100 mg Tablet.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Sofosbuvir + Velpatasvir may include:

• headache
• fatigue
• nausea
• trouble sleeping
• diarrhea
• weakness
• more noticeable tiredness if another hepatitis C medicine is added

• Tell your doctor if you have hepatitis B, because this medicine can reactivate it in some people.
• Use caution if you take amiodarone, as serious slow heartbeat can occur.
• Tell your clinician about all heart medicines, seizure medicines, and acid-reducing drugs before starting Hepcitaj-SV 400 mg/100 mg Tablet.
• Alcohol can further stress the liver, so ask your doctor whether you should avoid it during treatment.
• Do not use this tablet as a self-directed dose change; the 400 mg/100 mg strength is a fixed adult-style treatment dose chosen by a clinician.
• If you have severe kidney disease or advanced liver disease, your prescriber needs to review whether this exact product is appropriate.
• If you are pregnant, breastfeeding, or could become pregnant, discuss the risks and benefits before starting treatment.

• amiodarone
• rifampin and other strong enzyme inducers
• carbamazepine, phenytoin, phenobarbital, or oxcarbazepine
• St. John’s wort
• antacids, H2 blockers, and proton pump inhibitors

Store Hepcitaj-SV 400 mg/100 mg Tablet at room temperature in its original strip/box, away from excess heat, moisture, and direct light.